Format

Send to

Choose Destination
Clin Vaccine Immunol. 2013 Feb;20(2):218-26. doi: 10.1128/CVI.00546-12. Epub 2012 Dec 12.

Construction and nonclinical testing of a Puumala virus synthetic M gene-based DNA vaccine.

Author information

1
Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, USA.

Abstract

Puumala virus (PUUV) is a causative agent of hemorrhagic fever with renal syndrome (HFRS). Although PUUV-associated HFRS does not result in high case-fatality rates, the social and economic impact is considerable. There is no licensed vaccine or specific therapeutic to prevent or treat HFRS. Here we report the synthesis of a codon-optimized, full-length M segment open reading frame and its cloning into a DNA vaccine vector to produce the plasmid pWRG/PUU-M(s2). pWRG/PUU-M(s2) delivered by gene gun produced high-titer neutralizing antibodies in hamsters and nonhuman primates. Vaccination with pWRG/PUU-M(s2) protected hamsters against infection with PUUV but not against infection by related HFRS-associated hantaviruses. Unexpectedly, vaccination protected hamsters in a lethal disease model of Andes virus (ANDV) in the absence of ANDV cross-neutralizing antibodies. This is the first evidence that an experimental DNA vaccine for HFRS can provide protection in a hantavirus lethal disease model.

PMID:
23239797
PMCID:
PMC3571280
DOI:
10.1128/CVI.00546-12
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center